medmix AG (CH:MEDX)
:MEDX
Want to see CH:MEDX full AI Analyst Report?
Top Page
medmix AG
(MEDX)
Select Model
Select Model
Rating:52Neutral
Price Target:
CHF8.00
▼(-12.28% Downside)
Action:Reiterated
Date:03/03/26
The score is driven primarily by mixed financial performance (earnings rebound but thin margins, low ROE, and declining revenue) and weak technicals (below major moving averages with negative MACD). A high dividend yield helps, but it is offset by a very high P/E that limits the valuation score.
Positive Factors
Recurring consumables
medmix's business model includes recurring consumables and replacement components tied to installed dispensing systems, creating aftermarket revenue. Such recurring streams and qualification-driven switching costs in healthcare strengthen revenue visibility and deepen customer relationships over time.
Negative Factors
Soft revenue trend
A multi-year flat-to-declining top line constrains scale benefits and limits the company's ability to leverage fixed costs. Persistently weak revenue growth signals structural demand headwinds or competitive pressure and reduces long-term earnings growth potential and reinvestment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring consumables
medmix's business model includes recurring consumables and replacement components tied to installed dispensing systems, creating aftermarket revenue. Such recurring streams and qualification-driven switching costs in healthcare strengthen revenue visibility and deepen customer relationships over time.
Read all positive factors
medmix AG (MEDX) vs. iShares MSCI Switzerland ETF (EWL)
Market Cap
CHF325.97M
Dividend Yield4.54%
Average Volume (3M)115.75K
Price to Earnings (P/E)49.3
Beta (1Y)1.05
Revenue Growth-7.42%
EPS GrowthN/A
CountryCH
Employees2,684
SectorHealthcare
Sector Strength45
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)0.16
Shares Outstanding41,262,370
10 Day Avg. Volume183,978
30 Day Avg. Volume115,752
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)1.08
Price to Sales (P/S)1.02
P/FCF Ratio13.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.5
Revenue Forecast (FY)CHF448.64M
medmix AG Business Overview & Revenue Model
Company Description
Established in 1922 and headquartered in Zug, Switzerland, Medmix AG stands as a global leader in innovating, manufacturing, and distributing high-precision devices and services. These solutions are meticulously engineered for the controlled mixin...
How the Company Makes Money
medmix makes money primarily by selling mixing, dosing, and dispensing products and solutions to customers in its served end-markets. Key revenue streams typically include: (1) sales of dispensing and mixing devices/systems (e.g., applicators/disp...
medmix AG Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
58
Neutral
Cash Flow
63
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 448.00M | 483.90M | 486.60M | 477.10M | 457.30M |
| Gross Profit | 161.90M | 159.70M | 157.70M | 175.40M | 181.20M |
| EBITDA | 79.70M | 67.60M | 68.40M | 68.30M | 110.60M |
| Net Income | 6.40M | -7.40M | 300.00K | 11.60M | 44.00M |
Balance Sheet | |||||
| Total Assets | 969.30M | 954.20M | 1.01B | 1.11B | 974.40M |
| Cash, Cash Equivalents and Short-Term Investments | 113.90M | 96.20M | 130.60M | 316.80M | 210.00M |
| Total Debt | 330.30M | 323.40M | 349.70M | 473.50M | 320.90M |
| Total Liabilities | 536.50M | 507.50M | 532.40M | 601.10M | 440.50M |
| Stockholders Equity | 425.70M | 436.40M | 465.40M | 504.80M | 533.90M |
Cash Flow | |||||
| Free Cash Flow | 33.30M | 38.10M | 3.20M | 9.00M | 55.40M |
| Operating Cash Flow | 67.80M | 86.60M | 56.10M | 47.60M | 87.30M |
| Investing Cash Flow | -40.70M | -51.50M | -80.60M | -57.00M | -3.30M |
| Financing Cash Flow | -36.30M | -48.60M | -153.80M | 116.10M | 111.60M |
medmix AG Technical Analysis
Negative
9.12
Price Trends
8.62
Negative
9.17
Negative
9.55
Negative
Market Momentum
-0.18
Positive
24.80
Positive
11.71
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:MEDX, the sentiment is Negative. The current price of 9.12 is above the 20-day moving average (MA) of 8.48, above the 50-day MA of 8.62, and below the 200-day MA of 9.55, indicating a bearish trend. The MACD of -0.18 indicates Positive momentum. The RSI at 24.80 is Positive, neither overbought nor oversold. The STOCH value of 11.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:MEDX.
medmix AG Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | CHF269.37M | 8.44 | 13.91% | 2.43% | 2.10% | 16.14% | |
61 Neutral | CHF177.22M | 33.27 | ― | 3.45% | -10.52% | -54.90% | |
52 Neutral | CHF325.97M | 49.31 | ― | 4.54% | -7.42% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | CHF396.98M | -0.58 | ― | 7.53% | -20.25% | -559.45% | |
44 Neutral | CHF211.51M | -34.09 | ― | ― | -7.68% | -182.03% |
* Healthcare Sector Average
CH:MEDX
medmix AG
7.90
-4.05
-33.87%
CH:RIEN
Rieter Holding AG
3.01
-5.02
-62.55%
CH:KOMN
Komax Holding AG
41.25
-55.55
-57.39%
CH:MIKN
Mikron Holding AG
16.45
0.59
3.71%
CH:STGN
StarragTornos Group AG
32.60
-0.01
-0.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.